Litcius/Paper detail

Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122

Chofit Chai, Bryan D. Cox, Dayana Yaish, Devora Gross, Nofar Rosenberg, Franck Amblard, Zohar Shemuelian, Maytal Gefen, Amit Korach, Oren Tirosh, Tali Lanton, Henrike Link, Joseph Tam, Anna Permyakova, Günes Özhan, Jonathan Citrin, Haixing Liao, Mirna Tannous, Michal Hahn, Jonathan H. Axelrod, Enara Arretxe, Cristina Alonso, Ibon Martínez‐Arranz, Pablo Ortiz Betés, Rifaat Safadi, Ahmad Salhab, Johnny Amer, Zahira Tber, Seema Mengshetti, Hilla Giladi, Raymond F. Schinazi, Eithan Galun

2020Gastroenterology87 citationsDOIOpen Access PDF

Topics & Concepts

microRNAAgonistMiR-122Nonalcoholic fatty liver diseasePharmacologyChemistryMedicineInternal medicineFatty liverReceptorBiochemistryGeneDiseaseMicroRNA in disease regulationAdipokines, Inflammation, and Metabolic DiseasesLiver Disease Diagnosis and Treatment
Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122 | Litcius